Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Johnson & Johnson, soon transitioning its Orthopedics unit to DePuy Synthes, seeks a Business Unit Director for TECA and Sportsmed/Shoulder in Switzerland. You will own the full P&L, shape national strategy, and lead commercial and marketing teams to deliver profitable growth across this complex portfolio.
The role requires strategic leadership with hands-on execution plus fluency in German and English to engage with regional and global stakeholders.
Enterprise Management
Commercial Management
Professional
Zuchwil, Switzerland
The Business Unit Director – TECA (Trauma, Extremities, Animal Health & Craniomaxillofacial) and Sportsmed/Shoulder holds end-to-end accountability for strategy, growth, profitability, asset efficiency, and commercial execution of the TECA & Sportsmed/Shoulder business.
The role leads the TECA & Sportsmed/Shoulder commercial and marketing teams. This executive role requires strong strategic leadership combined with hands‑on operational execution across a complex portfolio.
Account Management, AI Judgement Integration, Client Management, Commercial Awareness, Commercial Laws, Commercial Management, Competitive Landscape, Compliance Management, Consulting, Corporate Management, Cross‑Functional Collaboration, Customer Effort Score, Customer Retentions, Leadership, Negotiation, Operational Excellence, Professional Ethics, Tactical Planning, Technical Credibility
Account Management, AI Judgement Integration, Client Management, Commercial Awareness, Commercial Laws, Commercial Management, Competitive Landscape, Compliance Management, Consulting, Corporate Management, Cross‑Functional Collaboration, Customer Effort Score, Customer Retentions, Leadership, Negotiation, Operational Excellence, Professional Ethics, Tactical Planning, Technical Credibility
On October 14, 2025, Johnson & Johnson announced plans to separate our Orthopedics business to establish a standalone orthopedics company, operating as DePuy Synthes. The planned separation is anticipated to be completed within 18 to 24 months, subject to legal requirements including consultation with works councils and other employee representative bodies, as may be required, regulatory approvals and other customary conditions and approvals.
It is anticipated following conclusion of the transaction, you would be an employee of DePuy Synthes, and your employment would be governed by Orthopedics employment processes, programs, policies, and benefit plans. Details of any planned changes would be provided to you by Orthopedics at an appropriate time and subject to any necessary consultation processes.
At Johnson & Johnson,we believe health is everything. Our strength in healthcare innovation empowers us to build aworld where complex diseases are prevented, treated, and cured,where treatments are smarter and less invasive, andsolutions are personal.Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.Learn more at jnj.com .
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.